" /> Noninvasive prenatal fetal aneuploidy and microdeletion panel:-:Pt:WBC.DNA Plas.cfDNA:-:Dosage of chromosome specific cf DNA - CISMeF





Preferred Label : Noninvasive prenatal fetal aneuploidy and microdeletion panel:-:Pt:WBC.DNA Plas.cfDNA:-:Dosage of chromosome specific cf DNA;

LOINC status : ACTIVE;

LOINC display name : Noninvasive prenatal fetal aneuploidy and microdel panel Dosage of chromosome-specific cfDNA (Plasma cell-free WBC DNA);

LOINC long common name : Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA;

LOINC short name : NIP aneu microdel pnl WBC.DNA cfDNA;

LOINC description : Noninvasive prenatal screening is used to assess fetal risk for various genetic conditions without requiring invasive maternal procedures such as amniocentesis or chorionic villus sampling. Cell-free DNA (cfDNA) in maternal plasma comes from both fetal and maternal sources, and depending on the technology used, this DNA can be used to determine fetal risk for a variety of conditions including aneuploidy (e.g., Trisomy 21, Monosomy X) and microdeletions (e.g., 22q11.2 deletion). This panel was developed for, but is not limited in use to, Natera's Panorama prenatal test, which incorporates SNP analysis of maternal white blood cell DNA with combined maternal and fetal cfDNA SNP analysis. Natera's proprietary informatics analysis method (NATUS) effectively subtracts the maternal genotype from the cfDNA genotype and analyzes the remaining fetal cfDNA genotype for certain aneuploidies and microdeletion syndromes.;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
29/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.